NASDAQ:IDGX - AltheaDx Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
AltheaDx, Inc. is a United States-based commercial-stage molecular diagnostics company. The Company is specialized in the field of pharmacogenetics. The Company focuses on enabling physicians, managed care organizations, pharmaceutical companies and other healthcare entities to make personalized therapeutic decisions for patients. The Company's IDgenetix pharmacogenetic testing portfolio addresses various clinical conditions in the United States, including cardiovascular disease, neuropsychiatric disorders and pain. The IDgenetix testing process consists of three steps: drug metabolism genotyping, drug response genotyping and algorithm screening. Its algorithm-based bioinformatic platform and pharmacogenetics product testing portfolio are intended to serve as a tool to assist healthcare providers in identifying optimal drugs for their patients, as well as dosing guidelines based on a patient's genetic make-up, prescription regimen and other key factors.

Receive IDGX News and Ratings via Email

Sign-up to receive the latest news and ratings for IDGX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-18.01%
Return on EquityN/A
Return on Assets-26.31%


Outstanding SharesN/A

The Truth About Cryptocurrencies

AltheaDx (NASDAQ:IDGX) Frequently Asked Questions

What is AltheaDx's stock symbol?

AltheaDx trades on the NASDAQ under the ticker symbol "IDGX."

Who are AltheaDx's key executives?

AltheaDx's management team includes the folowing people:
  • Francois Ferre Ph.D., Chairman of the Board
  • Jorge A. Garces Ph.D., President, Chief Executive Officer (Age 46)
  • Andrew Jackson, Chief Financial Officer
  • Joel Centeno, Senior Vice President, Regulatory Affairs and Quality Assurance
  • Andrew Lukowiak Ph.D., Senior Vice President - Operations

When did AltheaDx IPO?

(IDGX) raised $60 million in an initial public offering on Wednesday, February 11th 2015. The company issued 4,600,000 shares at a price of $12.00-$14.00 per share. Citigroup and Jefferies served as the underwriters for the IPO and William Blair and Cantor Fitzgerald were co-managers.

Has AltheaDx been receiving favorable news coverage?

Media coverage about IDGX stock has trended somewhat positive recently, Accern reports. The research firm rates the sentiment of media coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. AltheaDx earned a news impact score of 0.08 on Accern's scale. They also gave media stories about the company an impact score of 45.49 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the next several days.

How do I buy shares of AltheaDx?

Shares of IDGX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact AltheaDx?

AltheaDx's mailing address is 3550 Dunhill St, SAN DIEGO, CA 92121-1201, United States. The company can be reached via phone at +1-858-8820123.

MarketBeat Community Rating for AltheaDx (IDGX)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  8 (Vote Outperform)
Underperform Votes:  7 (Vote Underperform)
Total Votes:  15
MarketBeat's community ratings are surveys of what our community members think about AltheaDx and other stocks. Vote "Outperform" if you believe IDGX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IDGX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/24/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.